CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: Diagnostic and pathogenic significance

Pediatric Nephrology

Volumn 29, Issue 8, 2014, Pages 1363-1371

  Cara Fuentes, Gabriel ^a   Wei, Changli ^b   Segarra, Alfons ^c   Ishimoto, Takuji ^d   Rivard, Christopher ^d   Johnson, Richard J ^d   Reiser, Jochen ^b   Garin, Eduardo H ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

CD80; Focal segmental glomerulosclerosis; Minimal change disease; Nephrotic syndrome; suPAR

Indexed keywords

B7 ANTIGEN; CREATININE; UROKINASE RECEPTOR;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCRETION; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; KIDNEY DISEASE; MALE; MIDDLE AGED; MINIMAL CHANGE DISEASE; NEPHROTIC SYNDROME; PATHOGENICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RELAPSE; REMISSION; SCHOOL CHILD; URINARY EXCRETION; URINE LEVEL; YOUNG ADULT; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; KIDNEY FUNCTION TEST; NEPHROSIS, LIPOID; RECURRENT DISEASE; URINE;

ADOLESCENT; ANTIGENS, CD80; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY FUNCTION TESTS; MALE; NEPHROSIS, LIPOID; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RECURRENCE; YOUNG ADULT;

EID: 84903701749     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-013-2679-1     Document Type: Article

References (19)

1. Habib R, Kleinknecht C (1971) The primary nephrotic syndrome in childhood: classification and clinicopathologic study of 406 cases. Pathol Annu 6:417-474
2. Barisoni L, Schnaper HW, Kopp JB (2007) A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2:529-542
3. Kriz W, LeHir M (2005) Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 67:404-419 (Pubitemid 40139832)
4. Ponticelli C, Glassock RJ (2010) Treatment of primary glomerulonephritis, 2nd edn. Oxford University Press, New York, p 181
5. Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2:556-560
6. Sharma M, Sharma R, McCarthy ET, Savin VJ (1999) "The FSGS factor:" enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 10:552-561 (Pubitemid 29117637)
7. Reiser J, Mundel P (2004) Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome. J Am Soc Nephrol 15:2246-2248 (Pubitemid 39159324)
8. Franceschini N, North KE, Kopp JB, McKenzie L, Winkler C (2006) NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med 8:63-75
9. Clement LC, Avila-Casado C, Macé C, Soria E, Bakker WW, Kersten S, Chugh SS (2011) Podocyte-secreted Angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17:117-122
10. Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, Johnson RJ (2009) Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 20:260-266
11. Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ (2010) Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 78:296-302
12. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17:952-960
13. (1981) Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int 20:765-771
14. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC (2004) Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 43:368-382 (Pubitemid 38146337)
15. Reiser J, von Gersdorff G, Loos M, Oh L, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P (2004) Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113:1390-1397 (Pubitemid 39071694)
16. Wei C, Möller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, Xie L, Henger A, Schmid H, Rastaldi MP, Cowan P, Kretzler M, Parrilla R, Bendayan M, Gupta V, Nikolic B, Kalluri R, Carmeliet P, Mundel P, Reiser J (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14:55-63
17. Wei C, Trachtman H, Li J, Dong C, Friedman AL, Gassman JJ, McMahan JL, Radeva M, Heil KM, Trautmann A, Anarat A, Emre S, Ghiggeri GM, Ozaltin F, Haffner D, Gipson DS, Kaskel F, Fischer DC, Schaefer F, Reiser J, PodoNet and FSGS CT Study Consortia (2012) Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 23:2051-2059
18. Cara-Fuentes G, Araya C, Wei C, Rivard C, Ishimoto T, Reiser J, Johnson R, Garin EH (2013) CD80, suPAR and Nephrotic Syndrome in a case of NPHS2 mutation. Nefrologia 33:727-731
19. Shimada M, Ishimoto T, Lee PY, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Wymer DT, Yamabe H, Mathieson PW, Saleem MA, Garin EH, Johnson RJ (2012) Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-kB-dependent pathway. Nephrol Dial Transplant 27:81-89